ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IDD Innate Pharma

2.13
0.075 (3.65%)
22 Jul 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type
Innate Pharma TG:IDD Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.075 3.65% 2.13 2.13 2.17 2.06 2.06 2.06 20 22:50:06

Director Shareholding

17/10/2003 8:00am

UK Regulatory


RNS Number:0065R
ID Data PLC
17 October 2003

                                  SCHEDULE 11

          NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS



All relevant boxes should be completed in block capital letters.

1.    Name of company                                2.   Name of director



      ID Data plc                                         Peter Cox


3.    Please state whether notification indicates    4.   Name of the registered holder(s) and, if more than
      that it is in respect of holding of the             one holder, the number of shares held by each of
      shareholder named in 2 above or in respect of       them (if notified)
      a non-beneficial interest or in the case of an
      individual holder if it is a holding of that
      person's spouse or children under the age of
      18 or in respect of an non-beneficial interest      Peter Cox - 34,687,147

                                                          James Hay Pension Trustees Limited - 4,524,880

      As in 2 above




5.    Please state whether notification relates to a 6.   Please state the nature of the transaction. For PEP
      person(s) connected with the director named in      transactions please indicate whether general/single
      2 above and identify the connected person(s)        co PEP and if discretionary/non discretionary /non
                                                          discretionary


      N/A
                                                          Market disposal

7.    Number of shares/    8.   Percentage of issued 9.   Number of shares/      10. Percentage of issued
      amount of stock           class                     amount of stock            class
      acquired                                            disposed



                                                          1,000,000 on 15/10/03
                                                                                     0.47%
                                                          835,000 on 16/10/03
                                                                                     0.39%
                                                          (all from Peter Cox's
                                                          personal holding)

  11. Class of security    12.  Price per share      13.   Date of transaction   14.  Date company informed



      Ordinary Shares of        10.5p on 15/10/03          15/10/03 (1,000,000        16/10/03
      1p each                                              ords)
                                11.5p on 16/10/03
                                                           16/10/03 (835,000
                                                           ords)


15.   Total holding following this notification      16.   Total percentage holding of issued class following
                                                           this notification
      37,377,027 held as follows:
                                                           17.61%
      Peter Cox - 32,852,147

      James Hay Pension Trustees Limited - 4,524,880
If a director has been granted options by the company please complete the following boxes.
17.   Date of grant                                  18.  Period during which or date on which exercisable




19.   Total amount paid (if any) for grant of the    20.  Description of shares or debentures involved: class,
      option                                              number




21.   Exercise price (if fixed at time of grant) or  22.  Total number of shares or debentures over which
      indication that price is to be fixed at time        options held following this notification
      of exercise


23.   Any additional information                     24.  Name of contact and telephone number for queries

                                                          Martin Coles, 01536 207000



25.   Name and signature of authorised company official responsible for making this notification



      Martin Coles, Finance Director


Date of notification 17 October 2003






                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSNKAKDOBDDKKD

1 Year Innate Pharma Chart

1 Year Innate Pharma Chart

1 Month Innate Pharma Chart

1 Month Innate Pharma Chart